e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

9.570 -0.260 (-2.64%)

Streaming Delayed Price Updated: 12:27 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aptevo Therapeutics Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 29, 2021

Gainers Krystal Biotech (NASDAQ:KRYS) shares moved upwards by 118.21% to $86.87 during Monday's regular session. Krystal Biotech's stock is trading at a volume of...

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 01, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's...

Via Benzinga

Topics Intellectual Property

33 Stocks Moving In Monday's Mid-Day Session ↗

November 29, 2021

Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares jumped 116.4% to $86.13 after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational...

Via Benzinga

50 Biggest Movers From Yesterday ↗

November 30, 2021

Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 29, 2021

Gainers Krystal Biotech (NASDAQ:

Via Benzinga

25 Stocks Moving in Friday's Pre-Market Session ↗

November 26, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-...

Via Benzinga

56 Biggest Movers From Friday ↗

November 29, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 24, 2021

Gainers iSpecimen (NASDAQ:ISPC) shares in...

Via Benzinga

48 Stocks Moving In Friday's Mid-Day Session ↗

November 26, 2021

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 24, 2021

Gainers Biofrontera (NASDAQ:BFRI) shares ...

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

November 24, 2021

Gainers Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target. Longeveron Inc...

Via Benzinga

68 Biggest Movers From Wednesday ↗

November 26, 2021

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share. Longeveron Inc. (...

Via Benzinga

Topics Initial Public Offering

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 24, 2021

Gainers Ocuphire Pharma (NASDAQ:OCUP) stock rose 78.73% to $6.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $107.6...

Via Benzinga

28 Stocks Moving in Wednesday's Pre-Market Session ↗

November 24, 2021

Gainers Engine Gaming and Media, Inc. (NASDAQ: GAME) rose 51% to $4.80 in pre-market trading after the company reported Q4 2021 and FY21 revenue was higher year over year....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 24, 2021

We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 23, 2021

Gainers Biolase (NASDAQ:BIOL) shares incr...

Via Benzinga

56 Biggest Movers From Yesterday ↗

November 24, 2021

Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 100 Points; Zoom Video Shares Plunge ↗

November 23, 2021

Toward the end of trading Tuesday, the Dow traded up 0.29% to 35,723.97 while the NASDAQ fell 1.28% to 15,651.92. The S&P also fell, dropping 0.27% to 4,670.49. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA

Via Benzinga

Mid-Day Market Update: Nasdaq Tumbles Over 200 Points; Pasithea Therapeutics Shares Surge ↗

November 23, 2021

Midway through trading Tuesday, the Dow traded down 0.19% to 35,550.02 while the NASDAQ fell 1.45% to 15,624.16. The S&P also fell, dropping 0.63% to 4,653.33. The U.S. has...

Via Benzinga

Topics Stocks

36 Stocks Moving In Tuesday's Mid-Day Session ↗

November 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 216.6% to $7.00 after the company announced its subsidiary Pasithea Clinics has been approved to provide...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; Best Buy Posts Upbeat Q3 Earnings ↗

November 23, 2021

Following the market opening Tuesday, the Dow traded up 0.02% to 35,627.53 while the NASDAQ fell 0.58% to 15,762.28. The S&P also fell, dropping 0.14% to 4,676.49. The U.S....

Via Benzinga

Topics Stocks

Aptevo Stock Rallies After Posting First Complete Remission In Early Acute Myeloid Leukemia Trial ↗

November 23, 2021

Aptevo Therapeutics Inc (NASDAQ: APVO) has announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML). A high-...

Via Benzinga

Aptevo Therapeutics Reports First Complete Remission, Providing Clinical Update for Its Phase 1b Multi Center, Multi Cohort Expansion Trial in the Treatment of Acute Myeloid Leukemia

November 23, 2021

SEATTLE, WA / ACCESSWIRE / November 23, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology...

From Aptevo Therapeutics

Via AccessWire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 18, 2021

Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) shares moved upwards by 78.87% to $38.06 during Thursday's regular session. As of 12:30 EST, this security is trading at...

Via Benzinga

70 Biggest Movers From Yesterday ↗

November 16, 2021

Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...

Via Benzinga

Aptevo Therapeutics Announces the Presentation of Two Abstracts at the Upcoming American Society of Hematology Annual Meeting

November 15, 2021

SEATTLE, WA / ACCESSWIRE / November 15, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology...

From Aptevo Therapeutics

Via AccessWire

Looking Into Aptevo Therapeutics's Return On Capital Employed ↗

November 12, 2021

According to data from Benzinga Pro, during Q3, Aptevo Therapeutics's (NASDAQ:APVO) reported sales totaled $3.10 million. Despite a 16.99% increase in earnings, the company posted...

Via Benzinga

Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights

November 12, 2021

SEATTLE, WA / ACCESSWIRE / November 12, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology...

From Aptevo Therapeutics

Via AccessWire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy